FOMO, last patients final dosage is around first week of Jan.
We may get some initial findings there before the Q1 report comes out hopefully indicating positive results for all 16 patients and we move on to the final trial before we have a drug to market...yes that's a drug on the market.
Not to mention they may do a pilot trial with NASA which is a massive stamp of approval.
Watch how PAR has performed in repurposed drug market, we are very undervalued down here if we compare to our peers repurposing drugs.
SP Potential, page-3
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.012M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.9¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable